Digital pathology is not a single application—it is a platform supporting nine distinct clinical and research use cases. Each application has different technical requirements, regulatory environments, and value propositions. Understanding the application landscape is critical because:
This guide explores nine distinct applications, technical requirements, and implementation considerations for each.
Primary diagnosis is using digital pathology as the primary diagnostic pathway—pathologists review digital images instead of glass slides. This is the largest application, accounting for the majority of clinical digital pathology use. In primary diagnosis, organizations digitize their entire diagnostic workflow: specimens are scanned upon receipt, pathologists review only digital images (never touching glass slides), and diagnostic findings are documented and reported digitally.
Clinical Context: Primary diagnosis encompasses all routine pathology services: surgical pathology, cytopathology, autopsy pathology, and general diagnostic pathology. Any specimen can potentially be reviewed digitally rather than on glass slides.
Technical Requirements:
Regulatory Environment: Primary diagnosis is fully in IVDR scope—systems must be CE-marked. This is the most regulated application.
Value Drivers:
Implementation Complexity: Highest complexity. Requires comprehensive workflow redesign, staff training, and potential glass slide backup infrastructure. Organizations typically implement this application progressively—starting with low-risk specimens (benign cases) and expanding to high-complexity cases (cancer, rare diagnoses) over 2-3 years.
Second opinion consultation is using digital pathology to facilitate expert review of complex cases. Rather than physically mailing specimens or glass slides to expert centers, diagnostic images are digitally shared for remote review. Experts provide written consultation findings without requiring patient travel or specimen transport.
Clinical Context: Second opinion is used for difficult diagnostic cases—unusual histologic patterns, rare diagnoses, complex differential diagnoses. Patients, primary care pathologists, or hospital systems request expert review to confirm or clarify initial diagnoses.
Technical Requirements:
Regulatory Environment: Second opinion is clinical-use (IVDR scope). However, if consultation findings are explicitly labeled as "advisory" and primary care pathologists remain responsible for final diagnosis, some regulatory flexibility may apply. This is borderline case; organizations should verify with regulatory counsel.
Value Drivers:
Rapid expert access without patient/specimen travel
Implementation Complexity: Moderate complexity. Requires secure image sharing infrastructure and process changes for consultation workflows. Organizations typically implement this as a value-added service without major diagnostic workflow changes.
Telepathology is using digital pathology to extend expert diagnosticians across geographic regions. Rather than concentrating expertise in major academic centers, expert pathologists can provide remote consultation and diagnostic support across regional networks. This application is particularly valuable in underserved regions lacking specialized expertise (rare disease diagnostics, pediatric pathology, etc.).
Clinical Context: Telepathology serves two primary models:
1) Expertise extension—specialty centers providing remote consultation to regional hospitals.
2) Remote coverage—pathologists providing diagnostic coverage from home or satellite offices.
Technical Requirements:
Regulatory Environment: Telepathology is clinical-use (IVDR scope). Organizations must ensure systems support diagnostic workflows with appropriate verification and quality assurance.
Value Drivers:
Implementation Complexity: High complexity due to infrastructure requirements (high-bandwidth networks) and workflow changes (real-time consultation protocols). Implementation typically requires IT infrastructure investment and pathology workflow redesign.
Cancer diagnostics is using specialized digital pathology systems to support oncology diagnosis. Cancer pathology has unique requirements: quantitative biomarker measurement (Ki67 scoring, mitotic counting), tumor classification (TNM staging), prognostic factor assessment, and integration with genomic testing. Cancer diagnostic systems provide specialized tools for these oncology-specific requirements.
Clinical Context: Cancer diagnostics encompasses solid tumors (breast, lung, colon, skin cancers) and hematologic malignancies. All cancer diagnoses typically involve multiple pathology specialties and quantitative assessments.
Technical Requirements:
Regulatory Environment: Cancer diagnostics is fully IVDR scope. Quantitative biomarker algorithms may be classified as Class C (highest risk) requiring extensive clinical validation.
Value Drivers:
Implementation Complexity: High complexity due to specialized technical requirements and regulatory burden. Cancer centers typically implement cancer diagnostic systems first, given the high clinical and commercial value. Implementation timelines are 12-24 months due to clinical validation requirements.
Clinical trial pathology support is using digital pathology to manage and analyze pathology data in clinical trials. Pharmaceutical companies, contract research organizations (CROs), and academic institutions conducting clinical trials need to centralize pathology image review, standardize diagnostic assessment, and facilitate data analysis. Digital pathology platforms enable central image repositories, standardized assessment protocols, and quality assurance of trial pathology data.
Clinical Context: Clinical trials involving pathology require careful quality control of pathology data—trial protocol requires consistent diagnostic assessment across multiple clinical sites, often multiple countries. Digital pathology enables centralized image storage and centralized independent review.
Technical Requirements:
Regulatory Environment: Clinical trial pathology is typically research-use (IVDR exempt) because trial pathology is conducted specifically for research purposes rather than patient care. However, if trial pathology findings are used clinically to guide patient treatment, IVDR scope may apply.
Value Drivers:
Implementation Complexity: Moderate complexity. Implementation typically requires integration with sponsor's trial data systems and design of trial-specific assessment protocols. Timelines are 3-6 months depending on trial complexity.
Biomarker analysis and discovery is using digital pathology to identify and analyze disease biomarkers—molecular, histologic, or imaging features associated with disease or treatment response. Academic research institutions and biotech companies use digital pathology to conduct retrospective biomarker studies on archived pathology cohorts.
Clinical Context: Biomarker research asks questions like "What pathology features predict treatment response to this drug?" or "Are there histologic patterns that predict survival?" Digital pathology enables researchers to analyze large cohorts of archived cases to identify and validate biomarkers.
Technical Requirements:
Regulatory Environment: Biomarker research is research-use (IVDR exempt) because findings are not used clinically. However, if biomarkers are later validated and used clinically (e.g., companion diagnostics), IVDR scope applies to the clinical application.
Value Drivers:
Implementation Complexity: Moderate complexity. Requires integration with research data management and statistical analysis tools. Timelines are 2-4 months for research infrastructure.
Companion diagnostics is using digital pathology in conjunction with genomic testing to guide treatment selection. Pathology findings (tumor classification, biomarker assessment) are integrated with genomic test results to provide comprehensive treatment recommendations. Pharmaceutical companies develop companion diagnostic tests requiring specific pathology assessments before genomic testing can be interpreted.
Clinical Context: Companion diagnostics are used in precision medicine and targeted cancer therapy. Example: A patient with lung cancer undergoes both pathology assessment (tumor classification, PD-L1 scoring) and genomic testing (mutation analysis). Together, pathology + genomics guide selection of targeted therapy.
Technical Requirements:
Regulatory Environment: Companion diagnostics are IVDR-regulated (Class C—highest risk) because they directly guide treatment decisions. Clinical validation is extensive, and regulatory approval timelines are long (18-36 months).
Value Drivers:
Implementation Complexity: Highest complexity due to regulatory burden and specialized technical requirements. Implementation requires close vendor partnership, extensive clinical validation, and integration with oncology treatment planning systems. Timelines are 18-24 months.
Academic pathology is using digital pathology in medical education, pathology residency training, and clinical teaching. Medical schools and pathology residency programs use digital pathology systems to teach diagnostic concepts, standardize teaching case libraries, and enable remote learning.
Clinical Context: Academic pathology serves teaching missions—educating medical students, training pathology residents, and continuing professional development. Digital pathology enables access to case libraries and remote learning not possible with physical microscopes and glass slides.
Technical Requirements:
Regulatory Environment: Academic pathology is typically research-use or educational-use (IVDR exempt) because teaching cases are explicitly educational rather than clinical diagnostic. However, if teaching system findings are used clinically, IVDR scope applies.
Value Drivers:
Implementation Complexity: Low to moderate complexity. Implementation typically requires case curation and learning management integration. Timelines are 2-3 months.
Research pathology imaging is using digital pathology to support basic science research, translational research, and experimental pathology. Research institutions use digital pathology to analyze experimental specimens, archive research case materials, and enable collaborative research across institutions. Organizations pursuing digital transformation often partner with specialized digital pathology technology providers to accelerate implementation and adoption.
Clinical Context: Research pathology encompasses experimental animal pathology, human research tissue analysis, and translational research. Digital pathology enables researchers to archive and analyze research specimens with sophisticated image analysis.
Technical Requirements:
Regulatory Environment: Research pathology is research-use (IVDR exempt). Organizations have flexibility in implementation approaches.
Value Drivers:
Implementation Complexity: Moderate to high complexity depending on sophistication of image analysis requirements. Implementation timelines are 3-6 months.
Digital pathology applications utilize seven distinct image types, each with specialized technical requirements:
Standard tissue sections stained with hematoxylin and eosin (H&E). Histopathology is the most common image type, used for all primary diagnosis applications. Technical requirements: high resolution (0.25 microns/pixel), rapid retrieval, multi-image navigation.
Cell preparations (cervical cytology, body cavity fluids, brushings). Cytopathology images are typically smaller than histopathology but require different focus strategies (cells are distributed through preparation depth, not in single focal plane). Technical requirement: focus stacking to capture cells throughout preparation depth.
Tissue sections with immunostained markers (antibody staining). IHC requires assessment of staining intensity and distribution—important for biomarker scoring and companion diagnostics. Technical requirement: color calibration for accurate stain assessment.
Blood and bone marrow preparations. Hematopathology images are small (individual cells) and require high magnification. Technical requirement: high-resolution imaging at high magnification.
FISH (fluorescence in situ hybridization) images and other molecular preparations. FISH images use multiple fluorescence wavelengths. Technical requirement: multi-wavelength image capture and false-color rendering.
Intraoperative consultation pathology. Frozen section images are often lower quality (rapid preparation, limited staining) and require immediate availability (surgeon is waiting). Technical requirement: rapid image acquisition and immediate display.
Specialized research preparations (immunofluorescence, multiplex staining, experimental techniques). Research imaging often uses custom stains and non-standard preparations. Technical requirement: flexible multi-channel image capture.
Market adoption across hospitals, laboratories, and academic institutions is examined in the latest Europe Digital Pathology Industry Report. Real-world deployment is increasingly supported by AI-assisted diagnostics, image management systems, and remote consultation capabilities. Organizations should prioritize applications based on three factors: clinical value, technical feasibility, and organizational readiness.
Question: Which applications address the highest-priority clinical needs?
Question: Does your IT infrastructure and vendor ecosystem support the application?
Question: Is your organization prepared for the change management and workflow redesign?